Comparison of needle and syringe programme attendees and non-attendees from a high drug-using area in Sydney, New South Wales

References

• Gibson D R. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS 2001; 15: 1329–1341
   PubMed Web of Science ®Google Scholar
• Health Outcomes International Pty Ltd, National Centre in HIV Epidemiology and Clinical Research, Drummond M. Return on investment in needle and syringe programs in Australia: summary report. Commonwealth Department of Health and Ageing, Canberra 2002
   Google Scholar
• Levi G C, Vitoria M A. Fighting against AIDS: the Brazilian experience. AIDS 2002; 16: 2373–2383
   PubMed Web of Science ®Google Scholar
• Bluthenthal R N, Malik M, Grau L, Singer M, Marshall P, Heimer R. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities. Addiction 2004; 99: 1136–1146
   PubMed Web of Science ®Google Scholar
• Caiaffa W T, Proietti F A. Ecological analyses and the evaluation of needle and syringe programmes. Int J Drug Policy 2003; 14: 359–360
   Google Scholar
• Des Jarlais D C, Fisher D G, Newman J C, et al. Providing hepatitis B vaccination to injection drug users: referral to health clinics vs. on-site vaccination at a syringe exchange program. Am J Public Health 2001; 91: 1791–1792
   PubMed Web of Science ®Google Scholar
• Bluthenthal R N, Kral A H, Gee L, Erringer E A, Edlin B R. The effect of syringe exchange useon high-risk injection drug users: a cohort study. AIDS 2000; 14: 605–611
   PubMed Web of Science ®Google Scholar
• Fisher D, Fenaughty A, Cagle H, Wells R. Needle exchange and injection drug use frequency: a randomized clinical trial. J Acq Immune Defic Syndr 2003; 33: 199–205
   PubMed Web of Science ®Google Scholar
• Guydish J, Bucardo J, Clark G, Bernheim S. Evaluating needle exchange: a description of client characteristics, health status, program utilization, and HIV risk behavior. Subst Use Misuse 1998; 33: 1173–1196
   PubMed Web of Science ®Google Scholar
• Longshore D, Bluthenthal R N, Stein M. Needle exchange program attendance and injection risk in Providence, Rhode Island. AIDS Educ Prev 2001; 13: 78–90
   PubMed Web of Science ®Google Scholar
• MacDonald M. HIV and HCV infection and related risk behaviour among injecting drug users at selected Needle and Syringe Programs throughout Australia, 1995 – 1998. National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney 2001
   Google Scholar
• MacDonald M A, Wodak A D, Dolan K A, van Beek I, Cunningham P H, Kaldor J M. Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995 – 1997. Med J Aust 2000; 172: 57–61
   PubMed Web of Science ®Google Scholar
• Riley E, Safaeian M, Strathdee S, Brooner R, Beilenson P, Vlahov D. Drug user treatment referrals and entry among participants of a needle exchange program. Subst Use Misuse 2002; 37: 1869–1886
   PubMed Web of Science ®Google Scholar
• Riley E, Wu A, Junge B, Marx M, Strathdee S, Vlahov D. Health services utilization by injection drug users participating in a needle exchange program. Am J Drug Alcohol Abuse 2002; 28: 497–511
   PubMed Web of Science ®Google Scholar
• Stancliff S, Agins B, Rich J, Burris S. Syringe access for the prevention of blood borne infections among injection drug users. BMC Public Health 2003; 3: 37
   PubMedGoogle Scholar
• Vlahov D. The role of epidemiology in needle exchange programs. Am J Public Health 2000; 90: 1390–1392
   PubMed Web of Science ®Google Scholar
• National Centre in HIV Epidemiology and Clinical Research. Australian NSP survey national data report 1999 – 2003. National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney 2004
   Google Scholar
• Fisher D, Fenaughty A M, Cagle H H, Reynolds G L. Injection drug users' use of pharmacies for purchasing needles in Anchorage, Alaska. Int J Drug Policy 2003; 14: 381–387
   Google Scholar
• Miller C L, Tyndall M, Spittal P, Li K, Palepu A, Schechter M T. Risk-taking behaviours among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchange. J Urban Health 2002; 79: 257–265
   PubMed Web of Science ®Google Scholar
• Riley E, Safaeian M, Strathdee S, et al. Comparing new participants of a mobile versus a pharmacy-based needle exchange program. J AIDS 2000; 24: 57–61
   PubMed Web of Science ®Google Scholar
• Thein H, Denoe M, van Beek I, Dore G, MacDonald M. Injecting behaviour of injecting drug users at needle and syringe programmes and pharmacies in Australia. Int J Drug Policy 2003; 14: 425–430
   Google Scholar
• Lenton S, Kerry K, Loxley W, Tan-Quigley A, Greig R. Citizens who inject drugs: the ‘Fitpack’ study. Int J Drug Policy 2000; 11: 285–297
   PubMedGoogle Scholar
• Boutwell A, Rich J D. Syringe access for injection drug users in Rhode Island. Med Health Rhode Is 2004; 87: 15–16
   Google Scholar
• Khoshnood K, Kaplan E, Heimer R. ‘Dropouts’ or ‘drop-ins’? Client retention and participation in New Haven's needle exchange program. Public Health Rep 1995; 110: 462–466
   PubMed Web of Science ®Google Scholar
• Rich J, Strong L, Towe C, McKenzie M. Obstacles to needle exchange participation in Rhode Island. J Acq Immune Defic Syndr 1999; 21: 396–400
   PubMed Web of Science ®Google Scholar
• Trubnikov M N, Khodakevich L N, Barkov D A, Blagovo D V. Sources of injecting equipment for drug users in Moscow, Russia. Int J Drug Policy 2003; 14: 453–455
   Google Scholar
• Australian Institute of Health and Welfare. 2001 National Drug Strategy household survey: first results. Australian Institute of Health and Welfare, Canberra 2002
   Google Scholar
• South East Health HIV/AIDS and Related Disease Unit. South East Health needle and syringe program operating policies, procedures and guidelines manual. South East Health, Sydney 2003
   Google Scholar
• Henderson L, Vlahov D, Celetano D, Strathdee S. Readiness for cessation of drug use among recent attenders and nonattenders of a needle exchange program. J Acq Immune Defic Syndr 2003; 32: 229–237
   PubMed Web of Science ®Google Scholar
• Crofts N, Hopper J L, Milner R, Breshckin A M, Bowden D S, Locarnini S A. Blood-borne virus infections among Australian injecting drug users: Implications for spread of HIV. Eur J Epidemiol 1994; 10: 687–694
   Google Scholar
• Hagan H, DesJarlais D, Friedman S, Purchase D, Alter M J. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am J Public Health 1995; 85: 1531–1537
   PubMed Web of Science ®Google Scholar
• Bailey S L, Huo D, Garfein R S, Ouellet L J. The use of needle exchange by young injection drug users. J Acq Immune Defic Syndr 2003; 34: 67–70
   PubMed Web of Science ®Google Scholar
• Thein H H, Maher L, Kaldor J M, Dore G J. Hepatitis C prevalence and risk behaviours among high risk populations attending needle and syringe programs in Australia. 4th Australasian Conference on Hepatitis C, Canberra, 2004
   Google Scholar
• Richters J, Song A, Prestage G, Clayton S, Turner R. Health of lesbian, bisexual and queer women in Sydney. National Centre in HIV Social Research, Sydney 2005
   Google Scholar
• Prestage G, Jin F, Mao L, et al. Illicit drug use and HIV seroconversion in the health in men (HIM) cohort. 17th Annual Conference of the Australasian Society for HIV Medicine, Hobart, 2005
   Google Scholar